Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: New.
Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: As New. Unread book in perfect condition.
Sprache: Englisch
Verlag: Springer Berlin 25.02.1992., 1992
ISBN 10: 3540539492 ISBN 13: 9783540539490
Anbieter: NEPO UG, Rüsselsheim am Main, Deutschland
Unbekannt. Zustand: Sehr gut. 670 S. Sprache: Englisch Gewicht in Gramm: 1056.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 60,51
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: Chiron Media, Wallingford, Vereinigtes Königreich
EUR 57,31
Anzahl: 10 verfügbar
In den WarenkorbPF. Zustand: New.
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
EUR 60,27
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New.
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
EUR 66,61
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: As New. Unread book in perfect condition.
Anbieter: BargainBookStores, Grand Rapids, MI, USA
Paperback or Softback. Zustand: New. Acute Leukemias: Pharmacokinetics and Management of Relapsed and Refractory Disease. Book.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 84,80
Anzahl: 2 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 1st edition. 700 pages. 9.20x6.10x1.58 inches. In Stock.
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Following the major breakthroughs in the and frequent and thorough exchange of treatment of acute leukemias in the seven information. Hence, it was felt that a spe ties by the introduction of intensive combi cial series of symposia should be devoted to nation regimens, therapeutic progress has 'Pharmacokinetics and Management of slowed down and the impression of stagna Relapsed and Refractory Disease' comple menting the established meetings on 'Prog tion may even have occured. In contrast, the knowledge about the biology of leu nostic Factors and Treatment Strategies' kemias is rapidly expanding and allows new which will proceed in parallel. It was the insights into the pathophysiology of the aim of the international symposium disease. Further improvements also come 'ACUTE LEUKEMIAS - Pharmacokine from a better understanding of the pharma tics and Management of Relapsed and cokinetics and pharmacodynamics of cyto Refractory Disease' to provide an update static drugs and their mechanisms of action. of the present knowledge in this area and to Hence, novel treatment modalities can be stimulate further developments. As a sign developed on a more solid basis and ration for the closing distance between countries al. These achievements need to be comple and the development of effective world mented by effective eradiation wide cooperation this symposium emerged of residual disease or its permanent control and new from the joint efforts of the German AML approaches have been derived from recent Cooperative Group and the M. D.
Anbieter: preigu, Osnabrück, Deutschland
Taschenbuch. Zustand: Neu. Acute Leukemias | Pharmacokinetics and Management of Relapsed and Refractory Disease | W. Hiddemann (u. a.) | Taschenbuch | xxvi | Englisch | 1992 | Springer | EAN 9783540539490 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Sprache: Englisch
Verlag: Springer Berlin Heidelberg, Springer Berlin Heidelberg Feb 1992, 1992
ISBN 10: 3540539492 ISBN 13: 9783540539490
Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Deutschland
Taschenbuch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Following the major breakthroughs in the and frequent and thorough exchange of treatment of acute leukemias in the seven information. Hence, it was felt that a spe ties by the introduction of intensive combi cial series of symposia should be devoted to nation regimens, therapeutic progress has 'Pharmacokinetics and Management of slowed down and the impression of stagna Relapsed and Refractory Disease' comple menting the established meetings on 'Prog tion may even have occured. In contrast, the knowledge about the biology of leu nostic Factors and Treatment Strategies' kemias is rapidly expanding and allows new which will proceed in parallel. It was the insights into the pathophysiology of the aim of the international symposium disease. Further improvements also come 'ACUTE LEUKEMIAS - Pharmacokine from a better understanding of the pharma tics and Management of Relapsed and cokinetics and pharmacodynamics of cyto Refractory Disease' to provide an update static drugs and their mechanisms of action. of the present knowledge in this area and to Hence, novel treatment modalities can be stimulate further developments. As a sign developed on a more solid basis and ration for the closing distance between countries al. These achievements need to be comple and the development of effective world mented by effective eradiation wide cooperation this symposium emerged of residual disease or its permanent control and new from the joint efforts of the German AML approaches have been derived from recent Cooperative Group and the M. D. 700 pp. Englisch.
Sprache: Englisch
Verlag: Springer Berlin Heidelberg, 1992
ISBN 10: 3540539492 ISBN 13: 9783540539490
Anbieter: moluna, Greven, Deutschland
EUR 48,37
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Drug Resistance in Leukemia.- Multidrug Resistance and Its Circumvention in Acute Leukemia.- The Role of DNA Topoisomerase II in Multidrug Resistance in Human Leukemia.- Development of Sensitive Assays to Detect Antifolate Resistance in Leukemia Blasts.- Se.
Sprache: Englisch
Verlag: Springer, J.B. Metzler Feb 1992, 1992
ISBN 10: 3540539492 ISBN 13: 9783540539490
Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschland
Taschenbuch. Zustand: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Drug Resistance in Leukemia.- Hematopoietic Growth Factors in Leukemia Therapy.- Characterization of Complete Remission - Molecular Biologic and Cytogenetic Approaches.- Pharmacokinetics - Preclinical Investigations and Therapeutic Implications.- Clinical Trials in Relapsed and Refractory Acute Myeloid Leukemia.- Post Remission Therapy.- Idarubicin: New Aspects in the Treatment of Acute Leukemias.- Novantrone: Current Status and Future Trends in the Treatment of Leukemias and Lymphomas.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 700 pp. Englisch.